Crawford, Kiersten
Crawford, Kiersten was paid $143K by Medicaid between Feb 2020 and Oct 2024, across 24 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoCRAWFORD, KIERSTEN
RIVERSIDE, RI 02915
RIVERSIDE, RI 02915
33aNPI1376618934assigned 11/21/2006
33bProvider typeMidwife
28Total paid$143K
24GClaims2,658
24DCodes billed24
24AFirst – last monthFeb 2020 – Oct 2024
Compared with peers
Next to other Midwife providers in Rhode Island
Rank by total paid#1 of 9
Median peer was paid$53K
This provider vs. median2.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 394 | $22K | |
| 2021 | 355 | $17K | |
| 2022 | 366 | $21K | |
| 2023 | 935 | $47K | |
| 2024incomplete | 608 | $36K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 840 | 506 | $38K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 20% | 402 | 358 | $29K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 20% | 400 | 357 | $28K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3.7% | 142 | 107 | $5K |
| 87806 | 3.5% | 70 | 68 | $5K | |
| 86900 | 3.5% | 59 | 54 | $5K | |
| 86850 | 3.1% | 59 | 54 | $4K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 86 | 61 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.5% | 50 | 43 | $4K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2.4% | 44 | 42 | $3K |
| 86901 | 1.8% | 59 | 54 | $3K | |
| 86592 | 1.3% | 82 | 80 | $2K |
12 more codes
| 87340 | 1.3% | 48 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.2% | 31 | $2K |
| 86803 | 1.1% | 33 | $2K | |
| 88142 | <1% | 28 | $1K | |
| 85027 | <1% | 44 | $1K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 17 | $1K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $905.70 |
| 81001 | <1% | 26 | $684.69 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 13 | $453.54 |
| 81025 | <1% | 83 | $427.91 | |
| 86762 | <1% | 14 | $416.96 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13 | $113.10 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.